Carprodyl Quadri 120 mg Chewable Tablets for Dogs

See sections 3.3 and

Special precautions for safe use in the target species:
Use in aged dogs may involve additional risk. If such a use cannot be avoided, dogs
may require a reduced dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a
potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs should be avoided.
NSAID can cause inhibition of phagocytosis and hence in the treatment of inflammatory
conditions associated with bacterial infection, appropriate concurrent antimicrobial
therapy should be instigated.
As with other NSAID, photodermatitis during treatment with carprofen has been
observed in laboratory animals and in humans. These skin reactions have never been
observed in dogs.
Do not administer other NSAID concurrently or within 24 hours of each other.
Due to the good palatability of the tablet, they should be stored in a safe place out of
the reach of animals. Intake of dose exceeding the recommended number of tablets
may lead to severe adverse effects. If this is the case, seek veterinary assistance
immediately.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Wash hands after handling the veterinary medicinal product.
Special precautions for the protection of the environment:
Not applicable.